4.5 Article

SARS-CoV-2 vaccination and myocarditis or myopericarditis: population based cohort study

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article

Myocarditis following COVID-19 vaccination

Elisabeth Albert et al.

Radiology Case Reports (2021)

Article Medicine, General & Internal

Myocarditis after Covid-19 Vaccination in a Large Health Care Organization

Guy Witberg et al.

Summary: Among 2.5 million patients who received the BNT162b2 mRNA vaccine in a large Israeli health care system, the incidence of myocarditis at 42 days was 2.13 cases per 100,000 persons, with the highest incidence (10.69 per 100,000 persons) among male patients between the ages of 16 and 29 years. Most cases of myocarditis were mild or moderate.

NEW ENGLAND JOURNAL OF MEDICINE (2021)

Article Medicine, General & Internal

Myocarditis after BNT162b2 mRNA Vaccine against Covid-19 in Israel

D. Mevorach et al.

Summary: The incidence of myocarditis increased after receiving the BNT162b2 vaccine in Israel, particularly after the second dose among young male recipients. The clinical presentation of myocarditis after vaccination was usually mild.

NEW ENGLAND JOURNAL OF MEDICINE (2021)

Article Public, Environmental & Occupational Health

COVID-19 Vaccine Second-Dose Completion and Interval Between First and Second Doses Among Vaccinated Persons - United States, December 14, 2020-February 14, 2021

Jennifer L. Kriss et al.

MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT (2021)

Article Medicine, General & Internal

Surveillance for Adverse Events After COVID-19 mRNA Vaccination

Nicola P. Klein et al.

Summary: This study conducted interim analysis of safety surveillance data of mRNA COVID-19 vaccines and found that the incidence of selected serious outcomes within 1-21 days post-vaccination was not significantly higher compared with 22-42 days post-vaccination. Surveillance is ongoing despite wide confidence intervals for many outcomes.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2021)

Article Biochemistry & Molecular Biology

Long COVID in a prospective cohort of home-isolated patients

Bjorn Blomberg et al.

Summary: An analysis of patients with SARS-CoV-2 infections in Bergen, Norway, revealed that a high proportion of patients experienced long-term COVID symptoms at 6 months, even though they were relatively young and had only mild to moderate acute COVID-19 symptoms. This highlights the significance of infection control measures, such as vaccination.

NATURE MEDICINE (2021)

Article Medicine, General & Internal

Safety of the BNT162b2 mRNA Covid-19 Vaccine in a Nationwide Setting

Noam Barda et al.

Summary: The study found that after receiving the BNT162b2 vaccine, most adverse events were not associated with an increased risk, although there was a slight increase in the risk of myocarditis. On the other hand, infection with the Covid-19 virus significantly increased the risk of many serious adverse events.

NEW ENGLAND JOURNAL OF MEDICINE (2021)

Article Medicine, General & Internal

Multisystem Inflammatory Syndrome in Children - Initial Therapy and Outcomes

Mary Beth F. Son et al.

Summary: Initial treatment with IVIG plus glucocorticoids was associated with a lower risk of cardiovascular dysfunction compared to IVIG alone in children with MIS-C.

NEW ENGLAND JOURNAL OF MEDICINE (2021)

Article Pediatrics

Symptomatic Acute Myocarditis in 7 Adolescents After Pfizer-BioNTech COVID-19 Vaccination

Mayme Marshall et al.

Summary: This report presents 7 cases of acute myocarditis or myopericarditis in healthy male adolescents following the second dose of Pfizer-BioNTech COVID-19 vaccination, with patients rapidly recovering their symptoms through treatment with nonsteroidal anti-inflammatory drugs, intravenous immunoglobulin, and corticosteroids. The potential association between vaccine administration and myocarditis requires further monitoring and investigation.

PEDIATRICS (2021)

Article Immunology

Myocarditis following COVID-19 mRNA vaccination

Saif Abu Mouch et al.

Summary: This study reported six cases of myocarditis occurring shortly after BNT162b2 vaccination, all in young males with mild clinical course. All patients responded to the vaccine, and myocarditis post-BNT162b2 vaccination may be considered an adverse reaction.

VACCINE (2021)

Article Cardiac & Cardiovascular Systems

Myocarditis Following Immunization With mRNA COVID-19 Vaccines in Members of the US Military

Jay Montgomery et al.

Summary: This study investigated cases of myocarditis occurring in male patients within the US Military Health System after receiving mRNA COVID-19 vaccines between January and April 2021. A total of 23 male patients presented with acute chest pain within 4 days post-vaccination, with elevated troponin levels and findings consistent with myocarditis on imaging. The number of cases observed was higher than expected after a second dose of the vaccine among male military members.

JAMA CARDIOLOGY (2021)

Review Public, Environmental & Occupational Health

Existing Data Sources in Clinical Epidemiology: Laboratory Information System Databases in Denmark

Johan Frederik Hakonsen Arendt et al.

CLINICAL EPIDEMIOLOGY (2020)

Review Public, Environmental & Occupational Health

The Danish health care system and epidemiological research: from health care contacts to database records

Morten Schmidt et al.

CLINICAL EPIDEMIOLOGY (2019)

Review Public, Environmental & Occupational Health

The Danish Civil Registration System as a tool in epidemiology

Morten Schmidt et al.

EUROPEAN JOURNAL OF EPIDEMIOLOGY (2014)

Article Infectious Diseases

The Danish Microbiology Database (MiBa) 2010 to 2013

M. Voldstedlund et al.

EUROSURVEILLANCE (2014)

Article Medicine, General & Internal

Myopericarditis following smallpox vaccination among vaccinia-naive US military personnel

JS Halsell et al.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2003)